The stock of Advisory Board Company The (NASDAQ:ABCO) registered a decrease of 20.71% in short interest. ABCO’s total short interest was 1.47 million shares in September as published by FINRA. Its down 20.71% from 1.85 million shares, reported previously. With 225,900 shares average volume, it will take short sellers 7 days to cover their ABCO’s short positions. The short interest to Advisory Board Company The’s float is 3.92%. About 21,638 shares traded hands. The Advisory Board Company (NASDAQ:ABCO) has risen 3.90% since February 8, 2016 and is uptrending. It has underperformed by 12.59% the S&P500.
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The company has a market cap of $1.73 billion. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle, clinical activities and supply chain. It currently has negative earnings. The Company’s higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations.
The institutional sentiment decreased to 0.94 in 2016 Q2. Its down 0.01, from 0.95 in 2016Q1. The ratio dived, as 25 funds sold all The Advisory Board Company shares owned while 53 reduced positions. 28 funds bought stakes while 45 increased positions. They now own 39.77 million shares or 7.82% less from 43.15 million shares in 2016Q1.
Freshford Capital Management Llc holds 5.78% of its portfolio in The Advisory Board Company for 546,967 shares. Rivulet Capital Llc owns 515,000 shares or 4.92% of their US portfolio. Moreover, Ensemble Capital Management Llc has 4.39% invested in the company for 427,720 shares. The California-based Bernzott Capital Advisors has invested 3.67% in the stock. American Capital Management Inc, a New York-based fund reported 764,915 shares.
Out of 8 analysts covering Advisory Board (NASDAQ:ABCO), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. $64.0 is the highest target while $40 is the lowest. The $53.67 average target is 25.60% above today’s ($42.73) stock price. Advisory Board has been the topic of 9 analyst reports since October 12, 2015 according to StockzIntelligence Inc. Raymond James downgraded the stock on July 19 to “Market Perform” rating. KeyBanc Capital Markets downgraded the shares of ABCO in a report on April 18 to “Sector Weight” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.